Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Franchise Global Health Inc (MERCp)

TSXV
Currency in CAD
Disclaimer
0.15
0.00(0.00%)
Closed

MERCp Comments

Still staying tuned to the forthcoming news following the company requested a trade halt by Franchise Global Health. Many are speculating that this will be followed by likely significant news. Prior to this, they reached a milestone creating Europe’s first legal and registered seed bank in Denmark. Valued at $9.5M it’s arguably the largest seed bank in the world. Staying close to this announcement when it comes.
Big news is likely imminent as trading is halted for Franchise Global Health. They recently reached a significant milestone as well, creating Europe’s first legal and registered seedbank in Denmark - valued at $9.5M and arguably the largest in the world. Definitely keep an eye on the action once trading resumes.
Only a matter of time until markets reflect this recent and significant milestone from the company that’s dubbed the preeminent way to play the European cannabis boom. Franchise Global Health had just announced establishing Europe’s first legal and registered seedbank in Denmark - and it’s arguably the largest one in the world. Based on external auditing the seed bank is valued at $9.5M containing 286 strains that include winners of 19 cannabis cups.
Franchise Global Health announces a significant milestone establishing Europe’s first legal and registered seedbank in Denmark - this is arguably the largest seedbank globally and valued at $9.5M with 286 strains including winners of 19 cannabis cups. Another preeminent example for FGH on how to tap into the euro canna boom.
The German cannabis rush is real, with the German government set to fully legalize cannabis. Franchise Global Health is strongly positioned to fully tap into the early-mover advantages of growing the European cannabis market with their existing, fulsome distribution network of 1,200+ german pharmacies.
With the strong likelihood for the German government to legalize recreational cannabis, Franchise Global Health stands to fully reap their early-mover advantages in growing the European cannabis market with their existing and impressive distribution network of 1,200+ german pharmacies.
Franchise Global Health is setting the example on how to play the EU Cannabis boom - this is a solid analysis that highlights these facts. This fully integrated global cannabis company has serious early-mover advantages in Germany with the first import and distribution license, already selling to 1,200+ pharmacies. Furthermore, their sophisticated global distribution networks already span 18 countries.
Fueling the European Cannabis boom - Germany is set to become the largest legal cannabis market within the next 3 years, and legal cannabis sales in Germany are expected to reach $3B/year by 2026. There’s one company that’s setting the example on how to tap into the euro-canna boom and that’s Franchise Global Health that has the first import/distro license in Germany and is already selling to 1,200+ pharmacies in Germany.
This fully integrated global medical cannabis company has serious early-mover advantages in the growing European cannabis market. As the first recipient of a license to sell in Germany, award-winning genetics, cultivation expertise, and established distribution platforms, they are well on their way to be leaders in the European medical cannabis space.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.